drugset / Trial / NCT00931281
Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetics, safety and tolerability of multiple doses of an experimental hepatitis C virus (HCV) protease inhibitor with ritonavir in healthy volunteers.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | paritaprevir | Small molecule | — | — |
| Comparator | Ritonavir | Other / unclassified | — | — |